Overview

IMT for Primary Clostridium Difficile Infection

Status:
Terminated
Trial end date:
2017-11-16
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial to compare the effect of a 10-day course of per oral metronidazole versus a one-time rectal instillation of an anaerobically cultivated human intestinal microbiota for the treatment of a first occurrence of Clostridium difficile infection (CDI). Recurrent CDI is common after standard antibiotic treatment. We hypothesize that the instillation of a healthy intestinal microbiota will be more effective in inducing a durable cure than metronidazole for primary CDI.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Oslo University Hospital
Collaborator:
University of Oslo
Treatments:
Metronidazole